Related references
Note: Only part of the references are listed.Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens
Fernando Spiller et al.
JOURNAL OF IMMUNOLOGY (2018)
Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions
Amin Alborzian Deh Sheikh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Molecular basis of human CD22 function and therapeutic targeting
June Ereno-Orbea et al.
NATURE COMMUNICATIONS (2017)
Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec-Engaging Tolerogenic Liposomes
Lijuan Pang et al.
CHEMBIOCHEM (2017)
Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis
Christian Bull et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Synthesis and biological evaluation of 9-N-oxamyl sialosides as Siglec-7 ligands
Horst Prescher et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man
Matthew S. Macauley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Therapeutic Targeting of Siglecs using Antioody- and Glycan-Based Approaches
Takashi Angata et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Discovery of Multifold Modified Sialosides as Human CD22/Siglec-2 Ligands with Nanomolar Activity on B-Cells
Horst Prescher et al.
ACS CHEMICAL BIOLOGY (2014)
CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance
Lars Nitschke
GLYCOBIOLOGY (2014)
Deciphering key features in protein structures with the new ENDscript server
Xavier Robert et al.
NUCLEIC ACIDS RESEARCH (2014)
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
Marco Biasini et al.
NUCLEIC ACIDS RESEARCH (2014)
Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses
Derek C. Rookhuizen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
Cory D. Rillahan et al.
CHEMICAL SCIENCE (2014)
Siglec-mediated regulation of immune cell function in disease
Matthew S. Macauley et al.
NATURE REVIEWS IMMUNOLOGY (2014)
On-Chip Synthesis and Screening of a Sialoside Library Yields a High Affinity Ligand for Siglec-7
Cory D. Rillahan et al.
ACS CHEMICAL BIOLOGY (2013)
C-4 Modified Sialosides Enhance Binding to Siglec-2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy
Sorge Kelm et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
Matthew S. Macauley et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Copresentation of Antigen and Ligands of Siglec-G Induces B Cell Tolerance Independent of CD22
Fabian Pfrengle et al.
JOURNAL OF IMMUNOLOGY (2013)
CD22 Is Required for Protection against West Nile Virus Infection
Daphne Y. Ma et al.
JOURNAL OF VIROLOGY (2013)
Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation
Norihito Kawasaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling
Jennifer Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Toll-like Receptor 7 Is Required for Effective Adaptive Immune Responses that Prevent Persistent Virus Infection
Kevin B. Walsh et al.
CELL HOST & MICROBE (2012)
From a Library of MAG Antagonists to Nanomolar CD22 Ligands
Stefanie Mesch et al.
CHEMMEDCHEM (2012)
Targeting of CD22-positive B-cell lymphoma cells by synthetic divalent sialic acid analogues
Astrid Schweizer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
In Silico-Aided Design of a Glycan Ligand of Sialoadhesin for in Vivo Targeting of Macrophages
Corwin M. Nycholat et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
CD22-Antagonists with nanomolar potency: The synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold
Hajjaj H. M. Abdu-Allah et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
High affinity sialoside ligands of myelin associated glycoprotein
Ying Zeng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
CpG DNA as a vaccine adjuvant
Christian Bode et al.
EXPERT REVIEW OF VACCINES (2011)
Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response
Baidong Hou et al.
IMMUNITY (2011)
Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease
Robert C. Rickert et al.
IMMUNOLOGICAL REVIEWS (2011)
CD22 Regulates Adaptive and Innate Immune Responses of B Cells
Norihito Kawasaki et al.
JOURNAL OF INNATE IMMUNITY (2011)
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi et al.
NATURE (2011)
Toll-like Receptor 7 Controls the Anti-Retroviral Germinal Center Response
Edward P. Browne
PLOS PATHOGENS (2011)
In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Weihsu C. Chen et al.
BLOOD (2010)
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery
Stephanie Perot et al.
DRUG DISCOVERY TODAY (2010)
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo
Bao Hoa Duong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Augmented Antibody Response with Premature Germinal Center Regression in CD40L Transgenic Mice
Yusuke Kishi et al.
JOURNAL OF IMMUNOLOGY (2010)
Constitutive CD40L Expression on B Cells Prematurely Terminates Germinal Center Response and Leads to Augmented Plasma Cell Production in T Cell Areas
Anna Bolduc et al.
JOURNAL OF IMMUNOLOGY (2010)
CD22 x Siglec-G Double-Deficient Mice Have Massively Increased B1 Cell Numbers and Develop Systemic Autoimmunity
Julia Jellusova et al.
JOURNAL OF IMMUNOLOGY (2010)
Two physically, functionally, and developmentally distinct peritoneal macrophage subsets
Eliver Eid Bou Ghosn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Potent small molecule mouse CD22-inhibitors: Exploring the interaction of the residue at C-2 of sialic acid scaffold
Hajjaj H. M. Abdu-Allah et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
MetaPocket: A Meta Approach to Improve Protein Ligand Binding Site Prediction
Bingding Huang
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2009)
Synthesis of biotinylated sialoside to probe CD22-ligand interactions
Hajjaj H. M. Abdu-Allah et al.
TETRAHEDRON LETTERS (2009)
New horizons in adjuvants for vaccine development
Steven G. Reed et al.
TRENDS IN IMMUNOLOGY (2009)
Design, Synthesis, and Structure-Affinity Relationships of Novel Series of Sialosides as CD22-Specific Inhibitors
Hajaj H. M. Abdui-Allah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Fluorine in pharmaceuticals:: Looking beyond intuition
Klaus Mueller et al.
SCIENCE (2007)
Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation
Yuko Naito et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Crystallographic and in silico analysis of the sialoside-binding characteristics of the Siglec sialoadhesin
Nathan R. Zaccai et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
High-affinity ligand probes of CD22 overcome the threshold set by cis ligands for binding, endocytosis, and killing of B cells
Brian E. Collins et al.
JOURNAL OF IMMUNOLOGY (2006)
ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling
Prabhjit K. Grewal et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling
BE Collins et al.
NATURE IMMUNOLOGY (2006)
Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background
JC Poe et al.
JOURNAL OF IMMUNOLOGY (2004)
CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms
JC Poe et al.
NATURE IMMUNOLOGY (2004)
Molecular interactions regulate BCR signal inhibition by CD22 and CD72
L Nitschke et al.
TRENDS IN IMMUNOLOGY (2004)
Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells
Y Hokazono et al.
JOURNAL OF IMMUNOLOGY (2003)
Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin
NR Zaccai et al.
STRUCTURE (2003)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling
L Jin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound
S Kelm et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Postsource decay fragmentation of N-linked carbohydrates from ovalbumin and related glycoproteins
DJ Harvey
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2000)
Share Paper
